Age Related Macular Degeneration News and Research RSS Feed - Age Related Macular Degeneration News and Research

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020. [More]
Research provides new insight into possible causes of AMD among older people

Research provides new insight into possible causes of AMD among older people

Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older. [More]
Gut microbiota may play important role in influencing onset of blinding wet AMD

Gut microbiota may play important role in influencing onset of blinding wet AMD

Age-related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the industrialized world, affecting over 10 million individuals in North America. [More]
Discovery of novel protein could lead to potential new treatments for age-related retinal disease

Discovery of novel protein could lead to potential new treatments for age-related retinal disease

The discovery of a novel protein that links aging and age-dependent retinal diseases could lead to potential new treatments for conditions that cause sight loss in later life. [More]
Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I). [More]
Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

The long-term safety of gene transfer to treat neovascular age-related macular degeneration (NVAMD), and the production of two therapeutic proteins encoded by those genes for at least 2.5 years in the eyes of patients with advanced NVAMD are demonstrated in the results of a clinical trial published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Healthy fruit-rich Mediterranean diet may help protect against macular degeneration

Healthy fruit-rich Mediterranean diet may help protect against macular degeneration

People who closely follow the Mediterranean diet - -especially by eating fruit -- may be more than a third less likely to develop age-related macular degeneration, a leading cause of blindness, according to a study presented today at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology. [More]
Encapsulated cell therapy could be new way to fight glaucoma

Encapsulated cell therapy could be new way to fight glaucoma

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation. [More]
UEF research shows retinal changes may be detected earlier than brain changes

UEF research shows retinal changes may be detected earlier than brain changes

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye. [More]
Research findings offer promising treatment target for blinding diseases

Research findings offer promising treatment target for blinding diseases

New research published in Cell Reports identifies a potential treatment target for blinding diseases such as retinitis pigmentosa and advanced dry age-related macular degeneration. [More]
Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina. [More]
Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

In microseconds, every light ray that enters the eye triggers an explosion of coordinated cellular events. [More]
RPB continues research initiative to address urgent needs in treating low vision

RPB continues research initiative to address urgent needs in treating low vision

Research to Prevent Blindness is continuing its research initiative to address urgent needs in understanding and treating low vision. [More]
Research opens way towards making promising advances in retinal prostheses

Research opens way towards making promising advances in retinal prostheses

A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear. [More]
Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases. [More]
Researchers find potential way for delivering gene therapy to treat eye diseases

Researchers find potential way for delivering gene therapy to treat eye diseases

Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection. [More]
Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55. [More]
Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations. [More]
Buck researchers find new way for possible treatment of AMD

Buck researchers find new way for possible treatment of AMD

Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans. [More]
New research could pave way for improving retinal implants

New research could pave way for improving retinal implants

Engineers and neuroscientists at the University of Sheffield have demonstrated for the first time that the cells in the retina carry out key processing tasks. This could pave the way for improving retinal implants and therefore the sight of thousands of people suffering from retinal disorders. [More]
Advertisement
Advertisement